Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JKAPI-CKD study of pemafibrate in chronic kidney disease with hypertriglyceridemia
jRCTs031240097Active, not recruiting
- Sponsor
- Kowa Company, Ltd.
- Start
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of pemafibrate in chronic kidney disease (CKD) and hypertriglyceridemia (2 arms), sponsored by Kowa Company, Ltd. Primary endpoint: eGFR slope. Started Aug 2024; status: active, not recruiting.
02
Drugs
pemafibrate
03
Conditions
chronic kidney disease (CKD)hypertriglyceridemia
Beyond the preview
Go deeper on jRCTs031240097.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031240097.